August 29, 2016 8:41 PM ET

Pharmaceuticals

Company Overview of Allergan plc

Executive Profile

Brenton L. Saunders J.D.

Chief Executive Officer, President and Director, Allergan plc
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 13 different industries.

See Board Relationships
46$21,565,549
As of Fiscal Year 2015

Background

Mr. Brenton L. Saunders, also known as Brent, J.D., has been the Chief Executive Officer and President at Allergan plc since July 1, 2014. Mr. Saunders serves as the Chief Executive Officer and President of Actavis Plc. He has significant healthcare industry expertise and led various business transformations and integrations. He has an extensive experience negotiating and implementing corporate integrity agreements with state and federal agencies. He has extensive knowledge ...

Corporate Headquarters

Clonshaugh Business and Technology Park
Dublin, -- D17 E400

Ireland

Phone: 862 261-7000
Fax: --

Board Members Memberships

Trustee
Director
2014-Present
Chief Executive Officer, President and Director

Education

BA
University of Pittsburgh
JD
Temple University School Of Law
MBA
Fox School of Business and Management Temple University in Philadelphia

Other Affiliations

Annual Compensation

Salary$1,000,000
Total Annual Compensation$1,000,000

Stocks Options

All Other Compensation$315,325
Exercisable Options$199,900
Unexercisable Options$207,202
Total Number of Options$407,102

Total Compensation

Total Annual Cash Compensation$21,565,325
Total Short Term Compensation$1,000,000
Other Long Term Compensation$315,325
Total Calculated Compensation$21,565,549
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
Mark J. Alles Chief Executive Officer and Director
Celgene Corporation
$871.3K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
$21.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Allergan plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.